Very good for biotech investors in my view. These guys traded ahead of the news in both the highly-publicized ELN debacle and the less-known case of VPHM (a few years back) - plus more biotechs I'm sure we don't know about.
Biotech investing is hard enough even without playing against folks with loaded dice.
Market Data 
Markets 
AI
